Weight-loss drug maker Novo Nordisk invests $6 billion to boost output
COPENHAGEN (Reuters) – Novo Nordisk said on Friday it will invest more than 42 billion crowns ($6 billion) in its Danish production facility in the coming years to meet booming global demand for the Wegovy weight-loss treatment. The expansion at its Kalundborg site will boost capacity for manufacturing active pharmaceutical ingredients (API) as well as …
Weight-loss drug maker Novo Nordisk invests $6 billion to boost output Read More »










